218 related articles for article (PubMed ID: 8898452)
1. Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence.
Weiss HA; Forman D
Scand J Gastroenterol Suppl; 1996; 220():137-41. PubMed ID: 8898452
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
4. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
5. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.
García Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2000 Jul; 11(4):376-81. PubMed ID: 10874542
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents.
Greenberg ER; Baron JA
IARC Sci Publ; 1996; (139):91-8. PubMed ID: 8923021
[TBL] [Abstract][Full Text] [Related]
7. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.
García-Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
Peleg II; Maibach HT; Brown SH; Wilcox CM
Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and the prevention of colorectal cancer: a review of the evidence.
Paganini-Hill A
Semin Surg Oncol; 1994; 10(3):158-64. PubMed ID: 8085092
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
Baron JA
Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046
[TBL] [Abstract][Full Text] [Related]
13. Cancer: do aspirin and other NSAIDs protect against colorectal cancer?
Kraus S; Arber N
Nat Rev Gastroenterol Hepatol; 2011 Mar; 8(3):125-6. PubMed ID: 21243014
[No Abstract] [Full Text] [Related]
14. Aspirin and gastrointestinal cancer.
Thun MJ
Adv Exp Med Biol; 1997; 400A():395-402. PubMed ID: 9547582
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
Strul H; Arber N
Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
Logan RF; Little J; Hawtin PG; Hardcastle JD
BMJ; 1993 Jul; 307(6899):285-9. PubMed ID: 8374373
[TBL] [Abstract][Full Text] [Related]
17. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
Asano TK; McLeod RS
Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
[TBL] [Abstract][Full Text] [Related]
19. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
Dubé C; Rostom A; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
Ann Intern Med; 2007 Mar; 146(5):365-75. PubMed ID: 17339622
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
Huls G; Koornstra JJ; Kleibeuker JH
Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
